Infectious Mononucleosis
Showing 1 - 25 of 2,375
Study on Infectious Mononucleosis in Munich
Completed
- Infectious Mononucleosis
- Epstein-Barr Virus Infections
-
Munich, Bavaria, GermanyMRI Chonic Fatigue Center for Young People (MCFC), Children's Ho
Aug 16, 2023
Infectious Mononucleosis Trial in Edmonton (traditional Chinese acupuncture, standard medical care)
Terminated
- Infectious Mononucleosis
- traditional Chinese acupuncture
- standard medical care
-
Edmonton, Alberta, CanadaUniversity of Alberta
Jul 7, 2022
Epstein-Barr Virus Infection, Infectious Mononucleosis, Herpesvirus Trial run by the National Institute of Allergy and
Not yet recruiting
- Epstein-Barr Virus Infection
- +2 more
- Matrix-M1 Adjuvant
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Encephalomyelitis, Myalgic, Chronic Fatigue Syndrome, Chronic Fatigue Disorder Trial in Anchorage (Bupivacaine Injection)
Recruiting
- Encephalomyelitis, Myalgic
- +8 more
- Bupivacaine Injection
-
Anchorage, AlaskaNeuroversion
Jan 30, 2023
EBV, Epstein-Barr Virus Infection, Infectious Mononucleosis Trial run by the NIAID (EBV gp350-Ferritin Vaccine, Matrix-M1)
Recruiting
- EBV
- +2 more
- EBV gp350-Ferritin Vaccine
- Matrix-M1
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 11, 2022
HIV Indicator Diseases in Hospital and Primary Care
Recruiting
- HIV Infections
- +17 more
- Peer to peer feedback
- HIV rapid test
-
Rotterdam, South-Holland, NetherlandsCarlijn CCE Jordans
Jan 26, 2022
Point-of-Care Ultrasound in Diagnosis of Acute Infectious
Terminated
- Infectious Mononucleosis
- Splenomegaly
- Point-of-care ultrasound
-
Montreal, Quebec, Canada
- +1 more
Oct 4, 2020
Multiple Sclerosis Trial in Boston (Truvada (tenofovir/emtricitabine))
Enrolling by invitation
- Multiple Sclerosis
- Truvada (tenofovir/emtricitabine)
-
Boston, MassachusettsMassachusetts General Hospital
Jul 14, 2023
Munich ME/CFS Cohort Study
Recruiting
- Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (ICD-10 G93.3)
-
Munich, Bavaria, GermanyMRI Chronic Fatigue Center for Young People (MCFC), Children's h
Aug 16, 2023
Autoimmune Diseases, Lupus Erythematosus, Systemic, Communicable Diseases Trial in Atlanta
Enrolling by invitation
- Autoimmune Diseases
- +2 more
-
Atlanta, Georgia
- +2 more
May 17, 2022
ME/CFS, SARS CoV 2 Infection, Fatigue Syndrome, Chronic Trial in München
Recruiting
- ME/CFS
- +3 more
-
München, GermanyMünchen Klinik Schwabing
Mar 20, 2023
Early Detection of Epstein-Barr Virus Related Disease.
Active, not recruiting
- Post-transplant Lymphoproliferative Disorder
- +8 more
-
Aarhus, Central Region Of Denmark, DenmarkAarhus University Hospital
Dec 12, 2022
Genetic Studies of Chronic Active Epstein-Barr Disease
Recruiting
- Chronic Active Epstein-Barr Virus
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Epstein-Barr Virus Infection Trial in United States (mRNA-1189, Placebo)
Recruiting
- Epstein-Barr Virus Infection
- mRNA-1189
- Placebo
-
Hollywood, Florida
- +15 more
Jul 14, 2022
Epstein-Barr Virus Infection Trial in United States (mRNA-1195.1, mRNA-1195.2, mRNA-1189)
Recruiting
- Epstein-Barr Virus Infection
- mRNA-1195.1
- +3 more
-
Anniston, Alabama
- +29 more
Apr 14, 2023
Occurrence of Antibodies Cross-reacting With Autoantigens in
Recruiting
- Epstein-Barr Virus (EBV) Infection
- Data collection: Participant characteristics (Illness course, complications of primary EBV infection and provided treatments)
- +2 more
-
Basel, SwitzerlandUniversity Hospital Basel, Division of Internal Medicine
Nov 8, 2021
Multiple Sclerosis Trial in Muenster (311 nm narrowband UVB irradiation)
Recruiting
- Multiple Sclerosis
- 311 nm narrowband UVB irradiation
-
Muenster, NRW, GermanyUniversity Hospital Muenster
Nov 16, 2022
Serologically Active Adult Systemic Lupus Erythematosus Trial in Nantes, Paris (Autologous EBV specific CTL infusion)
Terminated
- Serologically Active Adult Systemic Lupus Erythematosus
- Autologous EBV specific CTL infusion
-
Nantes, France
- +2 more
Mar 24, 2022
Immunodeficiency for Severe Epstein-Barr Virus Infection
Recruiting
- Epstein-Barr Virus Infections
- Immunodeficiency
-
Shanghai, Shanghai, ChinaChildren's Hospital of Fudan University
Mar 21, 2022
Moderate to Severe Chronic Plaque-type Psoriasis Trial in Worldwide (secukinumab low dose, secukinumab high dose)
Active, not recruiting
- Moderate to Severe Chronic Plaque-type Psoriasis
- secukinumab low dose
- secukinumab high dose
-
Fountain Valley, California
- +22 more
Dec 24, 2022
Malignant Tumors Trial in Chengdu (EBV mRNA vaccine)
Recruiting
- Malignant Tumors
- EBV mRNA vaccine
-
Chengdu, Sichuan, ChinaWest China Hospital, Sichuan University
Jan 27, 2023
Herpes Zoster Keratitis Trial in Chicago (gancyclovir gel, Hypromellose gel)
Terminated
- Herpes Zoster Keratitis
- gancyclovir gel
- Hypromellose gel
-
Chicago, IllinoisNorthwestern University
Jun 16, 2021
EBV Infection Trial in Belgium (2LEBV® / 2LXFS®, Placebo)
Recruiting
- EBV Infection
- 2LEBV® / 2LXFS®
- Placebo
-
Aartselaar, Belgium
- +12 more
Dec 22, 2022
Infective Complications and Outcome of ALL Treated With INO
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +4 more
- (no location specified)
Aug 29, 2023
Genetic Susceptibility to Severe Infections
Not yet recruiting
- Infectious Disease
- Blood samples drawing
- Skin biopsy
- (no location specified)
Oct 20, 2023